Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

News Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Delayed Nasdaq Stockholm
Other stock markets
 03:13:08 2024-06-10 am EDT 		5-day change 1st Jan Change
5.52 SEK -12.45% Intraday chart for Clinical Laserthermia Systems AB -15.26% -80.00%
May. 31 Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue MT
May. 29 Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Clinical Laserthermia Systems publishes annual report for 2023
AQ
BioStock: CLS' partner initiates full market release in the US
AQ
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
AQ
CLS presents its new strategic direction in a Business Update Event on June 12
AQ
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
AQ
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
MT
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
AQ
CLS publishes interim report January - March 2024
AQ
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024
AQ
BioStock: CLS revises strategy - increases focus on neurosurgery
AQ
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
AQ
BioStock: CLS launches in France
AQ
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
AQ
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
CI
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
MT
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
AQ
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
AQ
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
AQ
BioStock: CLS makes progress in prostate cancer in Europe and the US
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB